For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative ...

MeiraGTx's financials show $125 million in cash, but additional funding will be needed within the next 12 months. Click for ...

Shares of Intra-Cellular Therapies Inc. (NASDAQ: ITCI) are trading higher Monday after Johnson & Johnson agreed to acquire ...

And GSK said it would pay up to $1.15 billion privately-held IDRx, a clinical-stage biopharmaceutical company developing therapeutics for the treatment of GIST, which stands for Gastrointestinal ...

Johnson & Johnson is starting the year off strong with a $14.6 billion acquisition of the biopharma firm Intra-Cellular Therapies — best known for its blockbuster drug Caplyta. The deal was announced ...

Josh Gad To Donate Some Portion Of His Memoir’s Proceeds To ... Kate Middleton Shows Gratitude To All Those Who ‘Quietly Walked Along’ During Her Cancer Treatment; Details Inside The Weeknd Pushes ...

The nature and the extent of change produced by these various forms of treatment are highly complex ... obsessive-compulsive disorder, or generalized anxiety disorder. Importantly, there is ...

Of more than 2,600 US healthcare workers who participated in a nationwide online panel survey from 2022 to 2023, 26% reported ...

Are you worried, restless, or having trouble concentrating most of the time? It could be anxiety. This common mental health ...

Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) ...

Psychedelic drug company Mind Medicine Inc. (MindMed) (NASDAQ: MNMD) published its 2025 Investor Presentation this week with ...